Are viral or host factors predictive of response to interferon-ribavirin in transplant patients with hepatitis C?
作者信息
Roche Bruno, Samuel Didier
出版信息
J Hepatol. 2010 May;52(5):630-2. doi: 10.1016/j.jhep.2010.01.023. Epub 2010 Feb 18.
PMID:20334948
Abstract
摘要
相似文献
1
Are viral or host factors predictive of response to interferon-ribavirin in transplant patients with hepatitis C?病毒或宿主因素能否预测丙型肝炎移植患者对干扰素-利巴韦林的反应？
J Hepatol. 2010 May;52(5):630-2. doi: 10.1016/j.jhep.2010.01.023. Epub 2010 Feb 18.
2
Rapid virological response to peginterferon and ribavirin for hepatitis C genotype 1: the role of weight-based ribavirin exposure.聚乙二醇干扰素和利巴韦林治疗丙型肝炎基因1型的快速病毒学反应：基于体重的利巴韦林暴露量的作用
Hepatology. 2008 Sep;48(3):1019-20; author reply 1020-1. doi: 10.1002/hep.22434.
3
Successful Hepatitis C Eradication With Preservation of Renal Function in a Liver/kidney Transplant Recipient Using Pegylated Interferon and Ribavirin.
Transplantation. 2007 Nov 27;84(10):1374-5. doi: 10.1097/01.tp.0000289996.37615.7d.
4
Benefit of pegylated interferon-alpha-2a/ribavirin in a patient with common variable immunodeficiency and hepatitis C virus cirrhosis after liver transplantation and splenic embolization.
Transplantation. 2006 Jul 27;82(2):289-90. doi: 10.1097/01.tp.0000226223.95971.e7.
5
Mutations in hepatitis C virus genotype 1b and the sensitivity of interferon-ribavirin therapy after liver transplantation.丙型肝炎病毒 1b 基因型的突变与肝移植后干扰素-利巴韦林治疗的敏感性。
J Hepatol. 2010 May;52(5):672-80. doi: 10.1016/j.jhep.2009.10.034. Epub 2010 Mar 4.
6
Predicting treatment outcome following 24 weeks peginterferon alpha-2a/ribavirin therapy in patients infected with HCV genotype 1: utility of HCV-RNA at day 0, day 22, day 29, and week 6.预测丙型肝炎病毒1型感染患者接受聚乙二醇干扰素α-2a/利巴韦林治疗24周后的治疗结果：第0天、第22天、第29天和第6周时丙型肝炎病毒核糖核酸的效用
Hepatology. 2007 Jan;45(1):258-9. doi: 10.1002/hep.21505.
7
Jaundice developing in a patient with hepatitis C4 months after liver transplantation.丙型肝炎患者肝移植4个月后出现黄疸。
Hepatology. 2009 Feb;49(2):695-6. doi: 10.1002/hep.22785.
8
Anemia in liver transplant recipients undergoing antiviral treatment for recurrent hepatitis C.
Liver Transpl. 2007 Jul;13(7):1032-8. doi: 10.1002/lt.21184.
9
Treatment of recurrent hepatitis C.
Liver Transpl. 2002 Oct;8(10 Suppl 1):S28-37. doi: 10.1053/jlts.2002.35860.
10
Effect of telaprevir on the pharmacokinetics of sirolimus in liver transplant recipients.替拉普韦对肝移植受者西罗莫司药代动力学的影响。
Liver Transpl. 2013 Apr;19(4):463-5. doi: 10.1002/lt.23623.
Zotero 插件